Cleared Traditional

K020217 - ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAY

K020217 is an FDA 510(k) clearance for ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAY, manufactured by Bayer Diagnostics Corp.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K020217 · Bayer Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2002
Decision
52d
Days
Class 1
Risk

K020217 is an FDA 510(k) clearance for the ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAY. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Bayer Diagnostics Corp. (Tarrytown, US). The FDA issued a Cleared decision on March 15, 2002 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bayer Diagnostics Corp. devices

FDA 510(k) Submission Details - K020217

510(k) Number K020217 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2002
Decision Date March 15, 2002
Days to Decision 52 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 88d · This submission: 52d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 421
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K020217.
CLINIQA LIQUID-QC HCG CONTROL LEVEL 1, 2, AND 3
K022232 · Cliniqa Corporation · Aug 2002
RNA GL4 GLUCOSE CALIBRATION VERIFICATION CONTROL, MODEL RNA CVC GL4
K021624 · Bionostics, Inc. · Jul 2002
GLUCOSE CONTROL SOLUTION FOR BD LATITUDE
K021697 · Bionostics, Inc. · Jul 2002
ELECSYS ANTI-TG CALCHECK
K020369 · Roche Diagnostics Corp. · Mar 2002
VITROS IMMUNODIAGNOSTIC PRODUCTS VITAMIN B12 RANGE VERIFIERS
K013900 · Ortho-Clinical Diagnostics · Dec 2001
VALIDATE CHEM 6 CALIBRATION VERIFICATION TEST SET MODEL # 10006
K013119 · Maine Standards Co. · Nov 2001